IL-6 and MYC collaborate in plasma cell tumor formation in mice

by Rutsch, Sebastian, Neppalli, Vishala T., Shin, Dong-Mi, DuBois, Wendy, Morse, Herbert C., Goldschmidt, Hartmut, Janz, Siegfried
Published 2010

Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility

by Zhang, Ke, Kagan, Daniel, DuBois, Wendy, Robinson, Richard, Bliskovsky, Valery, Vass, William C., Zhang, Shuling, Mock, Beverly A.
Published 2009

3’Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations

by Kovalchuk, Alexander L., Sakai, Tomomi, Qi, Chen-Feng, Du Bois, Wendy, Dunnick, Wesley A., Cogné, Michel, Morse, Herbert C.
Published in Oncotarget (2018)

Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene

by Bliskovsky, Valery, Ramsay, Edward S., Scott, John, DuBois, Wendy, Shi, Wei, Zhang, Shuling, Qian, Xiaolan, Lowy, Douglas R., Mock, Beverly A.
Published 2003

The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility

by Zhang, Shuling, Shi, Wei, Ramsay, Edward S., Bliskovsky, Valery, Eiden, Adrian Max, Connors, Daniel, Steinsaltz, Matthew, DuBois, Wendy, Mock, Beverly A.
Published in J Biol Chem (2019)

CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms

by Han, Seong-Su, Peng, Liangping, Chung, Seung-Tae, DuBois, Wendy, Maeng, Sung-Ho, Shaffer, Arthur L, Sporn, Michael B, Janz, Siegfried
Published 2006

Mouse tumor susceptibility genes identify drug combinations for multiple myeloma

by Zhang, Shuling, DuBois, Wendy, Zhang, Ke, Simmons, John K., Hughitt, V. Keith, Gorjifard, Sayeh, Gaikwad, Snehal, Peat, Tyler J., Mock, Beverly A.
Published in J Cancer Metastasis Treat (2020)

Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility

by Zhang, Shuling-L., DuBois, Wendy, Ramsay, Edward S., Bliskovski, Valeri, Morse, Herbert C., Taddesse-Heath, Leki, Vass, William C., DePinho, Ronald A., Mock, Beverly A.
Published 2001

Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia

by LeGrand, Jason, Park, Eun Sung, Wang, Hongyang, Gupta, Shalu, Owens, James D., Nelson, Patrick J., DuBois, Wendy, Bair, Thomas, Janz, Siegfried, Mushinski, J. Frederic
Published 2012

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer

by Malik, Navdeep, Yan, Hualong, Yang, Howard H., Ayaz, Gamze, DuBois, Wendy, Tseng, Yu-Chou, Kim, Young-Im, Jiang, Shunlin, Liu, Chengyu, Lee, Maxwell, Huang, Jing
Published in PLoS Genet (2021)

Susceptibility to Anthrax Lethal Toxin Is Controlled by Three Linked Quantitative Trait Loci

by McAllister, Ryan D., Singh, Yogendra, du Bois, Wendy D., Potter, Michael, Boehm, Thomas, Meeker, Nathan D., Fillmore, Parley D., Anderson, Lisa M., Poynter, Matthew E., Teuscher, Cory
Published 2003

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

by Smrž, Daniel, Kim, Mi-Sun, Zhang, Shuling, Mock, Beverly A., Smržová, Šárka, DuBois, Wendy, Simakova, Olga, Maric, Irina, Wilson, Todd M., Metcalfe, Dean D., Gilfillan, Alasdair M.
Published 2011

AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements

by Kovalchuk, Alexander L., duBois, Wendy, Mushinski, Elizabeth, McNeil, Nicole E., Hirt, Carsten, Qi, Chen-Feng, Li, Zhaoyang, Janz, Siegfried, Honjo, Tasuku, Muramatsu, Masamichi, Ried, Thomas, Behrens, Timothy, Potter, Michael
Published 2007

Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production

by Zhang, Shuling, Readinger, Julie A., DuBois, Wendy, Janka-Junttila, Mirkka, Robinson, Richard, Pruitt, Margaret, Bliskovsky, Val, Wu, Julie Z., Sakakibara, Kaori, Patel, Jyoti, Parent, Carole A., Tessarollo, Lino, Schwartzberg, Pamela L., Mock, Beverly A.
Published 2011

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells

by Wang, Hongsheng, Gonzalez-Garcia, Ines, Traba, Javier, Jain, Shweta, Conteh, Solomon, Shin, Dong-Mi, Qi, Chenfeng, Gao, Yuanyuan, Sun, Jiafang, Kang, Sungyun, Abbasi, Sadia, Naghashfar, Zohreh, Yoon, Jeongheon, DuBois, Wendy, Kovalchuk, Alexander L., Sack, Michael N., Duffy, Patrick, Morse, Herbert C.
Published in Sci Rep (2017)

Increased mammalian lifespan and a segmental and tissue-specific slowing of aging following genetic reduction of mTOR expression

by Wu, J. Julie, Liu, Jie, Chen, Edmund B., Wang, Jennifer J., Cao, Liu, Narayan, Nisha, Fergusson, Marie M., Rovira, Ilsa I., Allen, Michele, Springer, Danielle A., Lago, Cory U., Zhang, Shuling, DuBois, Wendy, Ward, Theresa, deCabo, Rafael, Gavrilova, Oksana, Mock, Beverly, Finkel, Toren
Published 2013

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

by Simmons, John K., Michalowski, Aleksandra M., Gamache, Benjamin J., DuBois, Wendy, Patel, Jyoti, Zhang, Ke, Gary, Joy, Zhang, Shuling, Gaikwad, Snehal, Connors, Daniel, Watson, Nicholas, Leon, Elena, Chen, Jin-Qiu, Kuehl, W. Michael, Lee, Maxwell P., Zingone, Adriana, Landgren, Ola, Ordentlich, Peter, Huang, Jing, Mock, Beverly A.
Published in Mol Cancer Ther (2017)

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells

by Sintes, Jordi, Gentile, Maurizio, Zhang, Shuling, Garcia-Carmona, Yolanda, Magri, Giuliana, Cassis, Linda, Segura-Garzón, Daniel, Ciociola, Alessandra, Grasset, Emilie K., Bascones, Sabrina, Comerma, Laura, Pybus, Marc, Lligé, David, Puga, Irene, Gutzeit, Cindy, He, Bing, DuBois, Wendy, Crespo, Marta, Pascual, Julio, Mensa, Anna, Aróstegui, Juan Ignacio, Juan, Manel, Yagüe, Jordi, Serrano, Sergi, Lloreta, Josep, Meffre, Eric, Hahne, Michael, Cunningham-Rundles, Charlotte, Mock, Beverly A., Cerutti, Andrea
Published in Nat Commun (2017)